Sir, Autologous hematopoietic stem cell transplant (HSCT) for Crohn's disease (CD) has been described by Oyama and co-workers as achieving remission in 11 out of 12 patients with refractory CD after a median follow-up of 18.5 months.1 They postulated that autologous HSCT was useful for refractory CD. We wish to report a case of a 32-year-old female patient with biopsy-proven CD diagnosed when she was 16 years old. ...please note that changes to the previously submitted letter have been underlined in the main body of text...
- Crohn's disease
- Stem cell
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.